|
Michael J. DuBois is senior vice president, Global Licensing and Strategic Alliances, for Schering-Plough Corporation.
DuBois joined Schering-Plough in his present position in September 2003. He is responsible for the acquisition of new products discovered outside Schering-Plough's laboratories to complement the activities of the company's internal drug discovery programs.
Previously, DuBois was senior vice president, Global Licensing, for Pharmacia Corporation, which has since merged with Pfizer. He also previously served as senior vice president, Corporate Licensing, for the former Pharmacia & Upjohn Company. During his tenure with Pharmacia, DuBois was instrumental in establishing companywide processes to improve Pharmacia's competitive position in pharmaceutical licensing.
DuBois holds B.S. degrees in chemistry and pharmacy from Rutgers, The State University of New Jersey. He earned an M.B.A. degree from the Rutgers Graduate School of Management.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com. | 